日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The mineralocorticoid receptor antagonist finerenone enhances cardiovascular recovery upon food intake normalization in obese mice.

盐皮质激素受体拮抗剂非奈利酮可增强肥胖小鼠在食物摄入量正常化后的心血管恢复。

Manon Monmirel-Fauconnier, Marie Pieronne-Deperrois, Benjamin Bonnard, Coralie Frimat, Linghui Kong, Amhrae Ni Dheasmhunaigh, Lionel Nicol, Saïda Morchid, Sylvanie Renet, Anaïs Dumesnil, Vincent Richard, Bruno Fève, Frédéric Jaisser, Sheerazed Boulkroun, Paul Mulder, Antoine Ouvrard-Pascaud

Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease

非甾体盐皮质激素受体拮抗剂 Finerenone 可改善临床前非糖尿病慢性肾病的舒张功能障碍

Ixchel Lima Posada, Matthieu Soulié, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frederic Jaisser

Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction

非甾体盐皮质激素受体拮抗剂 Finerenone 对射血分数保留的代谢综合征相关心力衰竭的益处

Ixchel Lima-Posada, Yohan Stephan, Matthieu Soulié, Roberto Palacios-Ramirez, Benjamin Bonnard, Lionel Nicol, Peter Kolkhof, Frederic Jaisser, Paul Mulder

Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

双糖蛋白聚糖是一种新型盐皮质激素受体靶点,与醛固酮/盐诱导的肾小球损伤有关

Toshifumi Nakamura, Benjamin Bonnard, Roberto Palacios-Ramirez, Amaya Fernández-Celis, Frédéric Jaisser, Natalia López-Andrés

The Absence of Endothelial Sodium Channel α (αENaC) Reduces Renal Ischemia/Reperfusion Injury

内皮钠通道 α (αENaC) 的缺失可减轻肾脏缺血/再灌注损伤

Antoine Tarjus, Cecilia González-Rivas, Isabel Amador-Martínez, Benjamin Bonnard, Rebeca López-Marure, Frédéric Jaisser, Jonatan Barrera-Chimal